GlassScriptPhysician profile
Brite J Chalunkal
NPI 1790917797
$643.94
in general payments reported to CMS, 2019-2025
15 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.48 · 2021: $13.16 · 2023: $269 · 2024: $166 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497 · Travel and Lodging: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.05 |
| Travel and Lodging | $117.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $174.06 | 2021-2025 | Intellis Adaptivestim |
| Abbvie INC. | $88.91 | 2023-2024 | Ubrelvy, Botox |
| Avanos Medical | $86.87 | 2024 | |
| Averitas Pharma INC. | $45.95 | 2023 | Qutenza |
| Valinor Pharma, LLC | $44.42 | 2023-2024 | Movantik |
| Collegium Pharmaceutical, INC. | $31.33 | 2023 | Xtampza |
| Si-Bone, INC. | $29.48 | 2023 | |
| Spinal Simplicity, LLC | $21.67 | 2024 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.36 | 2023 | Relistor |
| Bioventus LLC | $21.13 | 2023 | Durolane |
| Biotronik Nro, INC. | $18.24 | 2025 | Prospera |
| Tersera Therapeutics LLC | $16.48 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.86 | 2023 | Ztlido |
| Nalu Medical, INC. | $15.27 | 2025 | Nalu Neurostimulation System |
| Hikma Pharmaceuticals USA | $12.91 | 2023 | Kloxxado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brite Chalunkal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.